[HTML] plos.org

[HTML][HTML] BRAF Mutations in Advanced Cancers: Clinical Characteristics and Outcomes

H El-Osta, G Falchook, A Tsimberidou, D Hong… - PloS one, 2011 - journals.plos.org
Background Oncogenic BRAF mutations have been found in diverse malignancies and
activate RAF/MEK/ERK signaling, a critical pathway of tumorigenesis. We examined the …
被引用次数：120 相关文章
[HTML] nih.gov

[HTML][HTML] BRAF Mutations in Advanced Cancers: Clinical Characteristics and Outcomes

H El-Osta, G Falchook, A Tsimberidou, D Hong… - PLoS ONE, 2011 - ncbi.nlm.nih.gov
Background Oncogenic BRAF mutations have been found in diverse malignancies and
activate RAF/MEK/ERK signaling, a critical pathway of tumorigenesis. We examined the …
[PDF] researchgate.net

[PDF][PDF] BRAF Mutations in Advanced Cancers: Clinical Characteristics and Outcomes

H El-Osta, G Falchook, A Tsimberidou, D Hong… - 2011 - researchgate.net
Background: Oncogenic BRAF mutations have been found in diverse malignancies and
activate RAF/MEK/ERK signaling, a critical pathway of tumorigenesis. We examined the …

[引用][C] BRAF Mutations in Advanced Cancers: Clinical Characteristics and Outcomes

H El-Osta, G Falchook, A Tsimberidou, D Hong… - PLoS …, 2011 - ui.adsabs.harvard.edu
BRAF Mutations in Advanced Cancers: Clinical Characteristics and Outcomes - NASA/ADS Now
on home page ads icon ads Enable full ADS view NASA/ADS BRAF Mutations in Advanced …

BRAF mutations in advanced cancers: clinical characteristics and outcomes

H El-Osta, G Falchook, A Tsimberidou, D Hong… - PloS …, 2011 - pubmed.ncbi.nlm.nih.gov
Background Oncogenic BRAF mutations have been found in diverse malignancies and
activate RAF/MEK/ERK signaling, a critical pathway of tumorigenesis. We examined the …

BRAF Mutations in Advanced Cancers: Clinical Characteristics and Outcomes.

H El-Osta, G Falchook, A Tsimberidou, D Hong… - PLoS …, 2011 - search.ebscohost.com
Background: Oncogenic BRAF mutations have been found in diverse malignancies and
activate RAF/MEK/ERK signaling, a critical pathway of tumorigenesis. We examined the …

BRAF mutations in advanced cancers: Clinical characteristics and outcomes

H El-Osta, G Falchook, A Tsimberidou… - PloS …, 2011 - mdanderson.elsevierpure.com
Background: Oncogenic BRAF mutations have been found in diverse malignancies and
activate RAF/MEK/ERK signaling, a critical pathway of tumorigenesis. We examined the …

BRAF Mutations in Advanced Cancers: Clinical Characteristics and Outcomes

H El-Osta, G Falchook, A Tsimberidou, D Hong… - PLOS ONE, 2011 - ideas.repec.org
Background: Oncogenic BRAF mutations have been found in diverse malignancies and
activate RAF/MEK/ERK signaling, a critical pathway of tumorigenesis. We examined the …

BRAF Mutations in Advanced Cancers: Clinical Characteristics and Outcomes

H El-Osta, G Falchook, A Tsimberidou, D Hong… - PLoS ONE, 2011 - go.gale.com
Background Oncogenic BRAF mutations have been found in diverse malignancies and
activate RAF/MEK/ERK signaling, a critical pathway of tumorigenesis. We examined the …
[PDF] semanticscholar.org

[PDF][PDF] BRAF Mutations in Advanced Cancers: Clinical Characteristics and Outcomes

H El-Osta, G Falchook, A Tsimberidou, D Hong… - 2011 - pdfs.semanticscholar.org
Background: Oncogenic BRAF mutations have been found in diverse malignancies and
activate RAF/MEK/ERK signaling, a critical pathway of tumorigenesis. We examined the …